Printer Friendly

BIOPLASTY ANNOUNCES APPOINTMENT OF VICE PRESIDENT OF SALES AND MARKETING

BIOPLASTY ANNOUNCES APPOINTMENT OF VICE PRESIDENT OF SALES AND MARKETING
 ST. PAUL, Minn., April 13 /PRNewswire/ -- Bioplasty, Inc. (NASDAQ: BIOP) is pleased to announce the promotion of Daniel A. White to the position of vice president of Sales and Marketing. White joined Bioplasty, Inc. in February 1991, as the director of sales for the Plastic Surgery Division. In addition to being responsible for the domestic sales of Bioplasty's products, White will be involved in the market introduction of new products now in developmental and regulatory processes.
 "Dan's experience gives Bioplasty a strong foundation to assure the successful market launch of several products into the marketplace, such as the MISTI GOLD(TM) alternative gel-filled breast prostheses, and the SILDIMAC(TM) Delivery System(TM) to be used in the treatment of burns in burn centers and outpatient emergency rooms," stated Timothy Lawin, president and chief executive officer.
 Prior to joining Bioplasty, White had over 13 years of sales and sales management experience in the medical device industry, most recently with American Medical Systems where he was director of Domestic Sales.
 Bioplasty, Inc. has more than 20 years of experience in the development, manufacturing and marketing of plastic surgery products worldwide. Bioplasty's stock is currently traded on NASDAQ under the symbol "BIOP."
 -0- 4/13/92R
 /CONTACT: Timothy P. Lawin of Bioplasty, 612-636-4112/
 (BIOP) CO: Bioplasty, Inc. ST: Minnesota IN: MTC SU: PER


AL -- MN015R -- 7864 04/13/92 14:44 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 13, 1992
Words:239
Previous Article:SC BANCORP REPORTS FIRST QUARTER 1992 UNAUDITED FINANCIAL RESULTS
Next Article:NUTRAMAX PRODUCTS REPORTS RECORD SECOND QUARTER SALES AND EARNINGS


Related Articles
BIOPLASTY, INC. ANNOUNCES FISCAL 1992 OPERATING RESULTS
BIOPLASTY ANNOUNCES APPOINTMENT OF LINDA ALEXANDER TO THE POSITION OF DIRECTOR OF REGULATORY AFFAIRS
BIOPLASTY ANNOUNCES SECOND QUARTER RESULTS OF OPERATIONS
UROPLASTY ANNOUNCES APPOINTMENT OF PRESIDENT AND CHIEF EXECUTIVE OFFICER
BIOPLASTY ANNOUNCES RESIGNATION OF CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD
BIOPLASTY WITHDRAWS BREAST IMPLANTS OVERSEAS
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
UROPLASTY ANNOUNCES APPOINTMENT OF PRESIDENT
BIOPLASTY, INC. ANNOUNCES PROHIBITION OF SPIN OFF RECOMMENDED
BIOPLASTY, INC. ANNOUNCES RESIGNATION OF PRESIDENT AND CHIEF EXECUTIVE OFFICER

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters